- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05160025
Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease
December 4, 2023 updated by: Judith E Deutsch, PT, PhD, Rutgers, The State University of New Jersey
Enhancing Exercise Intensity, Motivation and Enjoyment for Persons With PD (VCycle-Competition)
This study has three objectives about persons with Parkinson's Disease during bicycling:
- Determine the effect of visual feedback and competition during virtual bicycling on neuromuscular and cardiovascular intensity
- Determine the effect of visual-feedback and competition during virtual bicycling on the user experience of motivation, enjoyment & perception of exercise intensity
- Determine if attention differs during visual feedback compared to competition virtual bicycling
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will attend one sessions lasting about 2-3 hours.
They will complete movement assessments and questionnaires about physical activity.
They will then exercise exercise in three different virtual reality augmented bicycling conditions while wearing a head mounted display (goggles).
Each of the three conditions will last approximately 8 minutes and will be followed by questionnaires about the participant's experience.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07107
- Rutgers School of Health Professions
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of Parkinson's disease following the UK Brain Bank Diagnostic Criteria,
- Hoehn and Yahr stages II-III,
- 45-80 years old,
- Able to ride a stationary upright bicycle,
- Able to sign informed consent.
Exclusion Criteria:
- Have a recent history of severe heart disease, severe lung disease, uncontrolled diabetes, traumatic brain injury or neurological disorder other than Parkinson Disease,
- Are unable to follow directions or sign a consent form,
- Do not have adequate vision or hearing ability to see or hear a television,
- Have unstable medical condition or musculoskeletal disorder such as severe arthritis, recent knee surgery, hip surgery, or any other condition that the investigators determine would impair the ability to ride the bicycle,
- Have any other medical condition that prevents bicycling,
- Have moderate depression (score of 9 or more on GDS screening tool).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Virtual Reality Bicycling
This is a single arm study in which all participants will execute the same three bicycling tasks over one session.
Exercise intensity and enjoyment are measured while participants bicycle in a virtual reality environment (wearing virtual reality goggles) in three different conditions lasting approximately 8 minutes each.
|
This is a single arm study in which all participants will execute the same three bicycling tasks over one session.
Exercise intensity and enjoyment are measured while participants bicycle in a virtual reality environment (wearing virtual reality goggles) in three different conditions lasting approximately 8 minutes each.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motivation (Intrinsic Motivation Inventory) - Feedback
Time Frame: Session 1 - Immediately after completing the 8-minute feedback bout
|
Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total).
Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation.
|
Session 1 - Immediately after completing the 8-minute feedback bout
|
|
Motivation (Intrinsic Motivation Inventory) - Self-Competition
Time Frame: Session 1 - Immediately after completing the 8-minute self-competition bout
|
Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total).
Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation.
|
Session 1 - Immediately after completing the 8-minute self-competition bout
|
|
Motivation (Intrinsic Motivation Inventory) - Other-Competition
Time Frame: Session 1 - Immediately after completing the 8-minute other-competition bout
|
Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total).
Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation.
|
Session 1 - Immediately after completing the 8-minute other-competition bout
|
|
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Feedback
Time Frame: Session 1 - During the 8-minute feedback bout
|
Bicycling cadence collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute feedback bout
|
|
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Self-Competition
Time Frame: Session 1 - During the 8-minute self-competition bout
|
Bicycling cadence collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute self-competition bout
|
|
Neuromuscular Intensity (Bicycling Cadence, Revolutions Per Minute) - Other-Competition
Time Frame: Session 1 - During the 8-minute other-competition bout
|
Bicycling cadence collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute other-competition bout
|
|
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Feedback
Time Frame: Session 1 - During the 8-minute feedback bout
|
Heart rate collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute feedback bout
|
|
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Self-Competition
Time Frame: Session 1 - During the 8-minute self-competition bout
|
Heart rate collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute self-competition bout
|
|
Cardiovascular Intensity (Heart Rate, Beats Per Minute) - Other-Competition
Time Frame: Session 1 - During the 8-minute other-competition bout
|
Heart rate collected continuously (1 value per second, 1 Hz)
|
Session 1 - During the 8-minute other-competition bout
|
|
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Feedback
Time Frame: Session 1 - During the 8-minute feedback bout
|
3D gaze positions are measured continuously (40 values per second, 40 Hz) and valid gaze datapoints are extracted.
The percentage of total valid gaze datapoints that are directed to the task are calculated as a metric of visual attention.
A higher percentage reflects higher task focus, meaning that the higher percentage the higher degree of focus on the task.
The reported value is measured as a percentage (%).
|
Session 1 - During the 8-minute feedback bout
|
|
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Self-Competition
Time Frame: Session 1 - During the 8-minute self-competition bout
|
3D gaze positions are measured continuously (40 values per second, 40 Hz) and valid gaze datapoints are extracted.
The percentage of total valid gaze datapoints that are directed to the task are calculated as a metric of visual attention.
A higher percentage reflects higher task focus, meaning that the higher percentage the higher degree of focus on the task.
The reported value is measured as a percentage (%).
|
Session 1 - During the 8-minute self-competition bout
|
|
Visual Attention (Infrared Eye-tracking Data Representing Gaze Positions in a 3D Coordinate Plane to be Used in Calculating Dwell Time in Regions of Interest in the Virtual Simulation) - Other-Competition
Time Frame: Session 1 - During the 8-minute other-competition bout
|
3D gaze positions are measured continuously (40 values per second, 40 Hz) and valid gaze datapoints are extracted.
The percentage of total valid gaze datapoints that are directed to the task are calculated as a metric of visual attention.
A higher percentage reflects higher task focus, meaning that the higher percentage the higher degree of focus on the task.
The reported value is measured as a percentage (%).
|
Session 1 - During the 8-minute other-competition bout
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ranking of Perceived Effort
Time Frame: Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
Once, after completing all 3 bicycling conditions, participants will be asked in which of the 3 bicycling conditions they felt they worked the hardest.
They will rank the 3 conditions with a score from 1-3, with a 1 indicating the condition in which they felt they worked the hardest and a 3 indicating the condition in which they felt they worked the least hard.
|
Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
|
Ranking of Enjoyment
Time Frame: Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
Once, after completing all 3 bicycling conditions, participants will be asked which of the 3 bicycling conditions they liked the best.
They will rank the 3 conditions with a score from 1-3, with a 1 indicating the condition they liked the best and a 3 indicating the condition they liked the least.
|
Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
|
Rating of Perceived Exertion - Feedback (Start)
Time Frame: Session 1 - Immediately at the start (0-minute mark) of the 8-minute feedback bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - Immediately at the start (0-minute mark) of the 8-minute feedback bout
|
|
Rating of Perceived Exertion - Feedback (Middle)
Time Frame: Session 1 - At the midpoint (4-minute mark) of the 8-minute feedback bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the midpoint (4-minute mark) of the 8-minute feedback bout
|
|
Rating of Perceived Exertion - Feedback (End)
Time Frame: Session 1 - At the endpoint (8-minute mark) of the 8-minute feedback bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the endpoint (8-minute mark) of the 8-minute feedback bout
|
|
Rating of Perceived Exertion - Self-Competition (Start)
Time Frame: Session 1 - Immediately at the start (0-minute mark) of the 8-minute self-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - Immediately at the start (0-minute mark) of the 8-minute self-competition bout
|
|
Rating of Perceived Exertion - Self-Competition (Middle)
Time Frame: Session 1 - At the midpoint (4-minute mark) of the 8-minute self-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the midpoint (4-minute mark) of the 8-minute self-competition bout
|
|
Rating of Perceived Exertion - Self-Competition (End)
Time Frame: Session 1 - At the end (8-minute mark) of the 8-minute self-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the end (8-minute mark) of the 8-minute self-competition bout
|
|
Rating of Perceived Exertion - Other-Competition (Start)
Time Frame: Session 1 - Immediately at the start (0-minute mark) of the 8-minute other-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - Immediately at the start (0-minute mark) of the 8-minute other-competition bout
|
|
Rating of Perceived Exertion - Other-Competition (Middle)
Time Frame: Session 1 - At the midpoint (4-minute mark) of the 8-minute other-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the midpoint (4-minute mark) of the 8-minute other-competition bout
|
|
Rating of Perceived Exertion - Other-Competition (End)
Time Frame: Session 1 - At the end (8-minute mark) of the 8-minute other-competition bout
|
Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts.
The score ranges from 6-20 with higher scores representing higher perceived exertion.
|
Session 1 - At the end (8-minute mark) of the 8-minute other-competition bout
|
|
Competitiveness (Multidimensional Competitive Orientation Inventory)
Time Frame: Measured once before exercise bouts begin (after clinical assessments) (Repeat of Baseline Outcome Measure)
|
Measured once using the Multidimensional Competitive Orientation Inventory consisting of 12 items from 4 subscales (hyper competitive, self-developmental, anxious, lack of interest) For each subscale, mean scores range from 1-6 with higher scores representing higher levels of that subscale metric.
|
Measured once before exercise bouts begin (after clinical assessments) (Repeat of Baseline Outcome Measure)
|
|
Audio Recordings of Exercise Experience
Time Frame: Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
Once, after completing all 3 bicycling conditions, participants will be asked about their exercise experience.
Quantitative and qualitative analysis of recordings were not conducted.
However, sample quotes representing constructs of the Intrinsic Motivation Inventory will be included in future publications.
|
Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
UPDRS-III Subscale
Time Frame: Collected once at start of the session (Repeat of Baseline Outcome Measure)
|
Description of Motor Performance Scored from 0-108 a lower score is better outcome
|
Collected once at start of the session (Repeat of Baseline Outcome Measure)
|
|
Physical Activity Scale for the Elderly
Time Frame: Collected once at start of the session (Repeat of Baseline Outcome Measure)
|
Exercise Inventory Questionnaire to measure levels of physical activity.
Scores range from 0-793, and higher scores represent higher levels of physical activity over the past 7 days.
|
Collected once at start of the session (Repeat of Baseline Outcome Measure)
|
|
Geriatric Depression Scale (Short Form)
Time Frame: Collected once during screening (Repeat of Baseline Outcome Measure)
|
15 item inventory to rate depression (scored from 0-15 with a lower score being better)
|
Collected once during screening (Repeat of Baseline Outcome Measure)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Judith E Deutsch, Rutgers School of Health Professions
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 27, 2022
Primary Completion (Actual)
February 17, 2023
Study Completion (Actual)
February 17, 2023
Study Registration Dates
First Submitted
October 26, 2021
First Submitted That Met QC Criteria
December 2, 2021
First Posted (Actual)
December 16, 2021
Study Record Updates
Last Update Posted (Actual)
December 22, 2023
Last Update Submitted That Met QC Criteria
December 4, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2021001412
- 1F30AG072807-01 (U.S. NIH Grant/Contract)
- 1R15AG063348-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Immediately following completion of the proposed study the investigators will submit a de-identified data set of the protocol and links to published papers.
IPD Sharing Time Frame
The investigators will make study data available immediately following completion.
IPD Sharing Access Criteria
Open Access
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Virtual reality bicycling
-
Rutgers, The State University of New JerseyCompleted
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA); New York Institute of TechnologyRecruitingParkinson DiseaseUnited States
-
Riphah International UniversityCompleted
-
Institut National de la Santé Et de la Recherche...RecruitingSchizophrenia | Bipolar DisorderFrance
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongCompleted
-
University of PennsylvaniaRecruiting
-
Istanbul University - CerrahpasaCompletedCancer | AnxietyTurkey
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
National University of MalaysiaRecruitingPleural EffusionMalaysia